Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$79.22 - $105.37 $46,739 - $62,168
-590 Reduced 6.78%
8,117 $827,000
Q1 2023

Jun 14, 2023

SELL
$30.85 - $93.17 $6,787 - $20,497
-220 Reduced 2.46%
8,707 $791,000
Q1 2023

May 11, 2023

SELL
$30.85 - $93.17 $6,787 - $20,497
-220 Reduced 2.46%
8,707 $792,000
Q4 2022

Jun 14, 2023

BUY
$22.15 - $42.11 $4,873 - $9,264
220 Added 2.53%
8,927 $339,000
Q4 2022

Feb 07, 2023

SELL
$22.15 - $42.11 $107,649 - $204,654
-4,860 Reduced 35.25%
8,927 $339,000
Q2 2022

Aug 05, 2022

BUY
$20.71 - $36.5 $16,568 - $29,200
800 Added 6.16%
13,787 $419,000
Q4 2021

Feb 08, 2022

SELL
$25.61 - $110.96 $14,315 - $62,026
-559 Reduced 4.13%
12,987 $342,000
Q3 2021

Nov 08, 2021

BUY
$100.0 - $143.02 $57,000 - $81,521
570 Added 4.39%
13,546 $1.36 Million
Q2 2021

Aug 10, 2021

SELL
$78.27 - $151.29 $1.52 Million - $2.95 Million
-19,476 Reduced 60.01%
12,976 $1.84 Million
Q1 2021

May 10, 2021

BUY
$94.25 - $132.81 $1,885 - $2,656
20 Added 0.06%
32,452 $3.24 Million
Q4 2020

Feb 08, 2021

BUY
$102.03 - $184.62 $249,871 - $452,134
2,449 Added 8.17%
32,432 $4.01 Million
Q3 2020

Nov 09, 2020

BUY
$93.53 - $163.34 $323,613 - $565,156
3,460 Added 13.05%
29,983 $2.92 Million
Q2 2020

Aug 07, 2020

BUY
$126.3 - $176.56 $2.09 Million - $2.92 Million
16,531 Added 165.44%
26,523 $4.14 Million
Q1 2020

May 05, 2020

BUY
$124.16 - $247.74 $98,086 - $195,714
790 Added 8.59%
9,992 $1.44 Million
Q4 2019

Feb 03, 2020

BUY
$74.57 - $217.92 $47,724 - $139,468
640 Added 7.47%
9,202 $1.88 Million
Q2 2019

Aug 05, 2019

BUY
$77.72 - $94.35 $51,295 - $62,270
660 Added 8.35%
8,562 $808,000
Q1 2019

May 03, 2019

BUY
$51.9 - $101.79 $15,051 - $29,519
290 Added 3.81%
7,902 $675,000
Q4 2018

Feb 01, 2019

BUY
$48.76 - $76.44 $33,449 - $52,437
686 Added 9.9%
7,612 $427,000
Q2 2018

Aug 06, 2018

BUY
$19.94 - $40.96 $138,104 - $283,688
6,926 New
6,926 $242,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.